The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.
Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Medicare premiums and deductibles have increased for all retirees. There's now a $2,000 cap on annual out-of-pocket ...
The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...
But actually, Medicare eligibility doesn't usually begin until age 65 (there can be exceptions for people with certain ...
The Affordable Care Act (ACA) set out to make healthcare more affordable. It had various effects on Medicare, such as ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
As of October 2022, Vascepa had coverage without restrictions for more than 90% of Medicare Part D enrollees, according to its manufacturer. According to Optum Perks, 30 capsules of Vascepa cost as ...